Navigation Links
The Leukemia & Lymphoma Society and The University of Kansas Cancer Center Announce Innovative Partnership to Accelerate Drug Development
Date:1/7/2009

WHITE PLAINS, N.Y. and KANSAS CITY, Kan., Jan. 7 /PRNewswire/ -- The Leukemia & Lymphoma Society (LLS) and The University of Kansas Cancer Center have announced a partnership to translate discoveries by LLS-funded researchers into Phase I clinical trials.

Currently, The University of Kansas Cancer Center (KU Cancer Center) and its partner, Beckloff Associates Inc., are supporting two early stage projects of LLS-funded researchers at The University of Virginia and The University of Toronto. The number of projects is expected to expand over the year.

The University of Kansas is uniquely positioned to work with LLS to accelerate the research it funds. KU Cancer Center has a long history of developing cancer drugs and currently has the No. 1 pharmacy school, in terms of National Institutes of Health (NIH) funding. KU Cancer Center holds a development contract with the National Cancer Institute (NCI) and has helped formulate seven out of the 19 drugs developed through NCI's Developmental Therapeutics Program.

Integral to moving projects rapidly into clinical trials is KU Cancer Center's partnership with industry. Beckloff Associates Inc., based in Overland Park, KS, provides development and regulatory support on the projects. Through these collaborative efforts and the formation of multi-disciplinary, multi-organizational, high-performance project teams, drug projects are advanced rapidly.

The partnership between KU Cancer Center and LLS is part of LLS's Therapy Acceleration Program, which supports private sector and academic-based projects with the goal of moving blood cancer therapies into the development pipeline. KU Cancer Center is the first academic partner in the program.

"By leveraging the capabilities and strengths The University of Kansas has in place, this partnership brings
'/>"/>

SOURCE The Leukemia & Lymphoma Society
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Grape Seed Extract Kills Leukemia Cells in Lab
2. Stem cells and leukemia battle for marrow microenvironment
3. Biopure Submits IND Application for Proposed Clinical Trial in Patients with Acute Myeloid Leukemia
4. Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
5. Dismissed leukemia drug helps cll patients, studies show
6. Novel treatments show improvements in survival and response rates for leukemia and lymphoma
7. Novel Treatments Demonstrate Improvements in Overall Survival and Response Rates in Difficult-To-Treat Forms of Leukemia and Lymphoma
8. 50 years of hairy-cell leukemia research to be observed
9. Higher Chemo Drug Dose Prolongs Lives of Leukemia Patients
10. Adult survivors of childhood leukemia have lower bone mineral density, study finds
11. UCSD researchers identify potential new drug target for chronic leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2009)...Newswire/ -- Ramsy Darwish knows what it,s like be... recent story called America,s "Other" Drug Prob...k Sanchez, Ramsy shared his story of addiction and...t the Narconon Freedom Center drug and alcohol...Send2Press.com/mediaboom/09-0703-NarcononMI_72dpi....
(Date:7/3/2009)...e that finding will lead to treatments, , ...archers say they,ve found a major cellular flaw th...cer. , When caught early, lung cancer can often... the disease is well advanced. Though doctors can ...se often springs back more virulent than ever, fre...
(Date:7/3/2009)... Eva,s Village, ( http://www.EvasVillage.org ), ...ks Buyers for 35mm Michael Jackson Film Print of &... Paterson, NJ (PRWEB) July 3, 2009 -- Eva...rofit New Jersey anti-poverty charity, seeks serio...Michael Jackson,s "Thriller" music video...
(Date:7/3/2009)... "This is an opportunity for you to change ...etic Free pills, you will experience a noticeable ... blood sugar, cholesterol levels and blood pressur...ized and your mind will finally be freed from the ...tes patient." , Miam...
Breaking Medicine News(10 mins):Health News:Narconon Graduate Successfully Recovers From Prescription Drug Abuse 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 2Health News:Cell Pathway May Be Key to Lung Cancer's Spread 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 2Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 3Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 4Health News:A New Jersey Charity Seeks Serious Inquiries for Historic 35mm Film Print of Michael Jackson's "Thriller" Music Video 5Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 2Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 3Health News:Patients Suffering from Diabetes Now Have the Option to Suffer No More with Diabetic Free All Natural Medical Herbal Extracts Capsules 4
...lass children's hospital has now proposed to let t...ith growing Concern being repeatedly raised about ...rvices as soon as they turn 13. NHS, Greater Glasg...ge for those to be treated at the children's hospi...
... team led by Dr Josephine Bowles and Professor Pet...ence at The University of Queensland, has// succes...uce sperm and females produce eggs. The findings w... This discovery is of great value and is thought t...
...sed of defrauding the NHS of more than ?600,000 ha...ld Michael Semeniuk of Willerby, near Hull carried...ich he filed around 3,500 cases of false claims fo...d that the claims were filed for treating dead pat...
...o possess ten times more anti-oxidants than in any...ng to Dutch researchers.// According to foodconsu...onal in Wageningen, the Netherlands, said flash fr...d storing them at minus 20 degrees Celsius destroy...
Other Medicine News:
(Date:6/26/2009)... BRIDGEWATER, N.J., June 26 /PRNewswire-FirstCall/...Y ) has just been made aware of data associated wi...tries. The results of these data clearly show that...a possible causal relationship between Lantus(R) (...urrence of malignancies, as the authors of the stu...
(Date:6/25/2009)... - Thirteen Renowned Medical Experts Slated to Att...Y., June 25 The first national sym...nergy drinks will be held next week in New York Ci...earch and analysis from their respective fields. ...ation and research on the health impacts that the ...
(Date:6/25/2009)... ACUROX(R) and EMBEDA (TM) Data Highlighted at the...ting , , RENO, Nev., June 25 ...ounced that the Company is presenting safety and e...1), two novel opioid analgesic formulations that a...he College on Problems of Drug Dependence. King i...
(Date:6/24/2009)... Preliminary top-line results of second Phase III ...d fatigue and improved daily function in fibromyal...ase III study , , PALO ALTO, Calif., and BRUSSE...se, regulated information -- Jazz Pharmaceuticals...s: UCB) announced today positive preliminary top-l...
Breaking Medicine Technology:Sanofi-aventis Stands Behind the Safety of Lantus(R) 2Sanofi-aventis Stands Behind the Safety of Lantus(R) 3SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 2SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 3SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts 4King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 2King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 3King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 4King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 5King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use 6Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints 2Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints 3Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints 4Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints 5Jazz Pharmaceuticals and UCB Announce Second Phase III Study of Sodium Oxybate in Patients With Fibromyalgia Meets Primary Endpoints 6Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing And The Importance Of New Medicare Related E 24000 1Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing And The Importance Of New Medicare Related E 24000 2Netsmart Technologies Web Seminar Helps Behavioral Health Organizations Understand Electronic Prescribing And The Importance Of New Medicare Related E 24000 3AMT Starts Collaboration With St Jude Childrens Research Hospital on Gene Therapy for Hemophilia B Company Accesses Exclusive Commercial Rights to F 6542 1AMT Starts Collaboration With St Jude Childrens Research Hospital on Gene Therapy for Hemophilia B Company Accesses Exclusive Commercial Rights to F 6542 2AMT Starts Collaboration With St Jude Childrens Research Hospital on Gene Therapy for Hemophilia B Company Accesses Exclusive Commercial Rights to F 6542 3AMT Starts Collaboration With St Jude Childrens Research Hospital on Gene Therapy for Hemophilia B Company Accesses Exclusive Commercial Rights to F 6542 4Family resources parenting quality influence childrens early cognitive development 23994 1Family resources parenting quality influence childrens early cognitive development 23994 2Tumor inhibiting protein could be effective in treating leukemia 4038 1Tumor inhibiting protein could be effective in treating leukemia 4038 2
...arch 12, 2007 /PRNewswire-FirstCall/ --,InB:Biotec...iary of,Integrated BioPharma, Inc. , today announc...against HPV, anthrax and plague made,using INBP,s ...The,studies were conducted by the Fraunhofer USA C...act Research Organization led by Dr.,Vidadi Yusibo...
...ch 13, 2007--Active Biotech AB,(Stockholm:ACTI.ST)...Q:CHTP) has performed a first human micro-dosing t...as to determine the pharmacokinetic,characteristic...ed,in healthy volunteers. , The study demonstrated...pharmacokinetic properties that make it well,suita...
Other Medicine Technology:Integrated Biopharma's Proprietary Vaccine Technology Achieves,Strong Positive Results 2Active Biotech's I-3D Micro-dosing Clinical Trial Concluded 2
Sterile perfluorocarbon for intraocular Application.
Alcon offers medical grade perfluoropropane (C3F8) intraocular gases for ophthalmological use.
Round knurled handle. Overall length 130 mm.
Optimum C/D/S Solution is a sterile cleaning, disinfecting, and storage solution for use with fluorosilicone acrylate and silicone acrylate rigid gas permeable (RGP) and hard contact lenses.
Medicine Products: